Harry W. Severance MD, FACEP

Harry W. Severance, MD, FACEP, Medical Director for the Erlanger Institute for Clinical Research, Erlanger emergency medicine physician, and Director of Clinical Research Trials at the University of Tennessee College of Medicine Chattanooga, has been selected to serve on the board of directors for the Duke University Cooperative Cardiovascular Society (DUCCS). Dr. Severance will serve a three-year term on the DUCCS board of directors. The DUCCS is a society of current and past Duke faculty members and fellows of Duke’s cardiovascular disease training program, along with clinical educators and investigators. The purpose of the DUCCS is to enhance the collaborative efforts of its members in cardiovascular research and continuing education. DUCKS supports the scholarly interests of its members by providing research and educational programs.